Accelerate PhenoTest BC试剂盒多中心评估:基于形态动力学细胞分析的快速鉴定与表型药敏试验
该多中心研究评估Accelerate Pheno系统,可在90分钟内从阳性血培养中鉴定常见血流病原体,并在约7小时内获得表型药敏结果。研究比较了该系统与Vitek 2鉴定及肉汤微量稀释法或纸片扩散法药敏的一致性,结果显示对14种常见细菌和2种念珠菌鉴定敏感性为94.6%至100%,革兰阳性菌和阴性菌的药敏一致率及错误率均在可接受范围。
要点
- Accelerate Pheno系统可在90分钟内鉴定阳性血培养中14种常见细菌和2种念珠菌。
- 革兰阳性菌药敏总体基本一致率97.6%,分类一致率97.9%,极重大错误率1.0%。
- 革兰阴性菌药敏总体基本一致率95.4%,分类一致率94.3%,极重大错误率0.5%。
核心结论
- Accelerate Pheno系统能直接从阳性血培养瓶快速提供表型MIC和分类药敏结果,支持准确的抗菌药物调整。
研究设计与样本
- 多中心研究,使用新鲜临床和人工接种血培养,将Accelerate Pheno系统结果与Vitek 2鉴定及肉汤微量稀释法或纸片扩散法药敏进行比较。
主要发现
- 系统准确鉴定14种常见细菌病原体和2种念珠菌,敏感性94.6%至100%。
- 89%的新鲜阳性血培养获得单微生物报告,阳性预测值97.3%。
- 革兰阳性菌4142个药敏结果:总体基本一致率97.6%,分类一致率97.9%,极重大错误率1.0%,重大错误率0.7%,小错误率1.3%。
- 革兰阴性菌6331个药敏结果:总体基本一致率95.4%,分类一致率94.3%,极重大错误率0.5%,重大错误率0.9%,小错误率4.8%。
关键数值与推荐
- 鉴定敏感性范围94.6%至100%(14种常见细菌和2种念珠菌)。
- 单微生物报告阳性预测值97.3%(新鲜阳性血培养中89%获得单微生物报告)。
- 革兰阳性菌药敏:基本一致率97.6%,分类一致率97.9%,极重大错误率1.0%,重大错误率0.7%,小错误率1.3%(4142个结果)。
- 革兰阴性菌药敏:基本一致率95.4%,分类一致率94.3%,极重大错误率0.5%,重大错误率0.9%,小错误率4.8%(6331个结果)。
临床怎么用
- 可利用该系统在数小时内从阳性血培养瓶直接获得鉴定和表型药敏结果,辅助临床早期调整抗菌治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We describe results from a multicenter study evaluating the Accelerate Pheno system, a first of its kind diagnostic system that rapidly identifies common bloodstream pathogens from positive blood cultures within 90 min and determines bacterial phenotypic antimicrobial susceptibility testing (AST) results within ∼7 h. A combination of fresh clinical and seeded blood cultures were tested, and results from the Accelerate Pheno system were compared to Vitek 2 results for identification (ID) and broth microdilution or disk diffusion for AST. The Accelerate Pheno system accurately identified 14 common bacterial pathogens and two Candida spp. with sensitivities ranging from 94.6 to 100%. Of fresh positive blood cultures, 89% received a monomicrobial call with a positive predictive value of 97.3%. Six common Gram-positive cocci were evaluated for ID. Five were tested against eight antibiotics, two resistance phenotypes (methicillin-resistant Staphylococcus aureus and Staphylococcus spp. [MRSA/MRS]), and inducible clindamycin resistance (MLSb). From the 4,142 AST results, the overall essential agreement (EA) and categorical agreement (CA) were 97.6% and 97.9%, respectively. Overall very major error (VME), major error (ME), and minor error (mE) rates were 1.0%, 0.7%, and 1.3%, respectively. Eight species of Gram-negative rods were evaluated against 15 antibiotics. From the 6,331 AST results, overall EA and CA were 95.4% and 94.3%, respectively. Overall VME, ME, and mE rates were 0.5%, 0.9%, and 4.8%, respectively. The Accelerate Pheno system has the unique ability to identify and provide phenotypic MIC and categorical AST results in a few hours directly from positive blood culture bottles and support accurate antimicrobial adjustment.
引用
- Pancholi P, Carroll KC, Buchan BW, et al. Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis. J Clin Microbiol. 2018. PMID: 29305546. doi:10.1128/JCM.01329-17
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。